-
Mashup Score: 0Up or Down: Chroma Medicine Raises Stakes in Epigenetic Editing - 1 year(s) ago
With $135 million in new financing, Chroma Medicine plans to present promising proof of concept data for its epigenetic genome editing platform, advance its pipeline, and grow its workforce.
Categories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 3Up or Down: Chroma Medicine Raises Stakes in Epigenetic Editing - 1 year(s) ago
With $135 million in new financing, Chroma Medicine plans to present promising proof of concept data for its epigenetic genome editing platform, advance its pipeline, and grow its workforce.
Categories: Future of Medicine, Latest HeadlinesTweet-
Up or Down: Chroma Medicine Raises Stakes in Epigenetic Editing @chromamedicine plans to present promising proof-of-concept data for its epigenetic #genomeediting platform, advance its pipeline, and grow its workforce. Read more: https://t.co/d0bJjwuX3y https://t.co/aWEtRrJADX
-
-
Mashup Score: 9
A recently patented genome editing tool called PASTE holds genuine promise for expanding the universe of treatable genetic diseases.
Categories: Future of Medicine, Latest HeadlinesTweet-
PASTE, Don’t Cut: Genome Editing Tool Looks Beyond #CRISPR and Prime A recently patented #genomeediting tool called PASTE holds genuine promise for expanding the universe of treatable genetic diseases. Learn more: https://t.co/oDekBn9TL4 https://t.co/01mQjO75Tg
-
-
Mashup Score: 8Up or Down: Chroma Medicine Raises Stakes in Epigenetic Editing - 1 year(s) ago
With $135 million in new financing, Chroma Medicine plans to present promising proof of concept data for its epigenetic genome editing platform, advance its pipeline, and grow its workforce.
Categories: Future of Medicine, Latest HeadlinesTweet-
Up or Down: Chroma Medicine Raises Stakes in Epigenetic Editing @chromamedicine plans to present promising proof-of-concept data for its epigenetic #genomeediting platform, advance its pipeline, and grow its workforce. Read more: https://t.co/d0bJjwvuT6 https://t.co/L28ChU66nW
-
-
Mashup Score: 1Search and Replace: Andrew Anzalone Details How Genome Editing Went Prime Time on “Close to the Edge” - 1 year(s) ago
Andrew Anzalone, MD, PhD, discusses his career in genome editing. He relates how he conceived the idea for prime editing, a “search and replace” gene editing approach, while he was a Jane Coffin Childs Memorial Fund postdoctoral fellow in the laboratory of David Liu, PhD.
Categories: Future of Medicine, Latest HeadlinesTweet-
Andrew Anzalone, MD, PhD, discusses his career in #genomeediting on Close to the Edge. He relates how he conceived the idea for #primeediting, while he was a Jane Coffin Childs Memorial Fund postdoctoral fellow in the laboratory of @davidrliu. Read more: https://t.co/cy5GX3nU9t https://t.co/t4nZPAIFkk
-
-
Mashup Score: 1One Third of Americans Would Use Genetics Tech to Make Their Offspring Smarter, Study Finds - 1 year(s) ago
Imagine walking around in a world where one out of every three people had had their genes tweaked before birth.
Source: Singularity HubCategories: Healthcare Professionals, Latest HeadlinesTweet-
A study found that one-third of Americans would be interested in using genetics tech to make their babies smarter. It's a dangerous direction for society as we don't know enough about #genomeediting yet to safely use it in practice. https://t.co/4Za9kFonkn
-
-
Mashup Score: 0Online Event - 1 year(s) ago
Register Overview Presenters ☰ Friday, February 10, 20238 am PT, 11 am ET, 17:00 CET Already Registered? Click HereA decade after its initial development, CRISPR genome editing is showing great promise for the treatment of previously intractable diseases, with exciting results reported in early clinical…
Source: www.workcast.comCategories: Future of Medicine, Latest HeadlinesTweet-
Join us on TOMORROW for @GENBiotechJrnl's inaugural Keynote webinar sponsored by @Taconic as Professor Erik Sontheimer @ESontheimerLab presents his team’s advances in #invivo #genomeediting. Click here to register for free: https://t.co/W5lA4UBCMx #CRISPR https://t.co/mSA2WCkiDv
-
-
Mashup Score: 0Online Event - 1 year(s) ago
Register Overview Presenters ☰ Friday, February 10, 20238 am PT, 11 am ET, 17:00 CET Already Registered? Click HereA decade after its initial development, CRISPR genome editing is showing great promise for the treatment of previously intractable diseases, with exciting results reported in early clinical…
Source: www.workcast.comCategories: Future of Medicine, Latest HeadlinesTweet-
Join us on February 10 for @GENBiotechJrnl's inaugural Keynote webinar sponsored by @Taconic as Professor Erik Sontheimer @ESontheimerLab presents his team’s advances in #invivo #genomeediting. Click here to register for free: https://t.co/W5lA4UBCMx #CRISPR https://t.co/FIISGemR9G
-
-
Mashup Score: 1Online Event - 1 year(s) ago
Register Overview Presenters ☰ Friday, February 10, 20238 am PT, 11 am ET, 17:00 CET Already Registered? Click HereA decade after its initial development, CRISPR genome editing is showing great promise for the treatment of previously intractable diseases, with exciting results reported in early clinical…
Source: www.workcast.comCategories: Future of Medicine, Latest HeadlinesTweet-
Join us on February 10 for @GENBiotechJrnl's inaugural Keynote webinar sponsored by @Taconic as Professor Erik Sontheimer @ESontheimerLab presents his team’s advances in #invivo #genomeediting. Click here to register for free: https://t.co/W5lA4UBCMx #CRISPR https://t.co/zpLo6pWNvz
-
-
Mashup Score: 0Online Event - 1 year(s) ago
Register Overview Presenters ☰ Friday, February 10, 20238 am PT, 11 am ET, 17:00 CET Already Registered? Click HereA decade after its initial development, CRISPR genome editing is showing great promise for the treatment of previously intractable diseases, with exciting results reported in early clinical…
Source: www.workcast.comCategories: Future of Medicine, Latest HeadlinesTweet-
Join us on February 10 for @GENBiotechJrnl's inaugural Keynote webinar sponsored by @Taconic as Professor Erik Sontheimer @ESontheimerLab presents his team’s advances in #invivo #genomeediting. Click here to register for free: https://t.co/W5lA4UCaC5 #CRISPR https://t.co/obaKxtt7zv
-
Up or Down: Chroma Medicine Raises Stakes in Epigenetic Editing @chromamedicine plans to present promising proof-of-concept data for its epigenetic #genomeediting platform, advance its pipeline, and grow its workforce. Read more: https://t.co/d0bJjwuX3y https://t.co/F8DDgPiwg8